KAO JOHN E 4

4 · Alignment Healthcare, Inc. · Filed Mar 19, 2026

AI-generated summary of this filing

Updated Mar 19, 2026

Alignment Healthcare (ALHC) CEO John Kao Sells 73,046 Shares

What Happened

John E. Kao, CEO of Alignment Healthcare, sold 73,046 shares on 2026-03-18 in an open-market transaction. The weighted-average sale price was $17.84 per share for total proceeds of about $1,303,141. The per-share sales ranged from $17.40 to $18.24. This was a sale to cover tax withholding related to the vesting of restricted stock units, not a discretionary trade.

Key Details

Transaction date: 2026-03-18 (reported on Form 4 filed 2026-03-19) — filing appears timely.
Transaction type/code: Sale (S); weighted-average price $17.84; price range $17.40–$18.24.
Shares sold: 73,046; gross proceeds ≈ $1,303,141.
Shares owned after transaction: Not specified in the Form 4 filing.
Notable footnotes:
- F1: Sale represents shares sold to cover tax withholding on RSU vesting (not discretionary).
- F2: Reported price is weighted-average; multiple trades occurred across the $17.40–$18.24 range. Full per-price breakdown available on request.
- F3: Some securities are held by the JEK Trust (Mr. Kao is trustee).

Context

This was a routine sell-to-cover following RSU vesting (a common practice for executives) and does not necessarily indicate a change in the CEO’s view of the company. Financially meaningful purchases tend to be more informative about insider conviction; this transaction was specifically for tax withholding.

Form 4

Period: 2026-03-18

DirectorChief Executive Officer

Transactions

Sale
Common Stock
[F1][F2]
2026-03-18$17.84/sh−73,046$1,303,141→ 1,784,868 total

Holdings

Footnotes (3)

[F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
[F2]The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
[F3]Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Signature

/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao|2026-03-19

1 file